THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0·6 mg/kg (THAWS) Trial

International Journal of Stroke

Volumn 9, Issue 8, 2014, Pages 1117-1124

  Koga, Masatoshi ^a   Toyoda, Kazunori ^a   Kimura, Kazumi ^b   Yamamoto, Haruko ^a   Sasaki, Makoto ^c   Hamasaki, Toshimitsu ^d   Kitazono, Takanari ^e   Aoki, Junya ^b   Seki, Kenta ^a   Homma, Kazunari ^a   Sato, Shoichiro ^a   Minematsu, Kazuo ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

^c IWATE MEDICAL UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e KYUSHU UNIVERSITY   (Japan)

Author keywords

Acute ischemic stroke; Clinical trials; Diffusion weighted imaging; Fluid attenuated inversion recovery imaging; Thrombolysis; Unclear onset time

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DRUG EFFICACY; DRUG SAFETY; ELECTRON SPIN RESONANCE; HUMAN; JAPANESE (PEOPLE); MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; STROKE PATIENT; SYMPTOM; ADULT; AGED; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; JAPAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; PROSPECTIVE STUDY; STROKE; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; JAPAN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84920404562     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12360     Document Type: Article

References (29)

1. Hacke W, Kaste M, Bluhmki E etal. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359:1317-1329.
2. Lees KR, Bluhmki E, von Kummer R etal. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375:1695-1703.
3. Mackey J, Kleindorfer D, Sucharew H etal. Population-based study of wake-up strokes. Neurology 2011; 76:1662-1667.
4. Kang DW, Kwon JY, Kwon SU, Kim JS. Wake-up or unclear-onset strokes: are they waking up to the world of thrombolysis therapy? Int J Stroke 2012; 7:311-320.
5. Koton S, Tanne D, Bornstein NM. Ischemic stroke on awakening: patients' characteristics, outcomes and potential for reperfusion therapy. Neuroepidemiology 2012; 39:149-153.
6. Todo K, Moriwaki H, Saito K, Tanaka M, Oe H, Naritomi H. Early CT findings in unknown-onset and wake-up strokes. Cerebrovasc Dis 2006; 21:367-371.
7. Serena J, Davalos A, Segura T, Mostacero E, Castillo J. Stroke on awakening: looking for a more rational management. Cerebrovasc Dis 2003; 16:128-133.
8. Marsh EE 3rd, Biller J, Adams HP Jr etal. Circadian variation in onset of acute ischemic stroke. Arch Neurol 1990; 47:1178-1180.
9. Aoki J, Kimura K, Iguchi Y, Shibazaki K, Sakai K, Iwanaga T. FLAIR can estimate the onset time in acute ischemic stroke patients. J Neurol Sci 2010; 293:39-44.
10. Thomalla G, Rossbach P, Rosenkranz M etal. Negative fluid-attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less. Ann Neurol 2009; 65:724-732.
11. Petkova M, Rodrigo S, Lamy C etal. MR imaging helps predict time from symptom onset in patients with acute stroke: implications for patients with unknown onset time. Radiology 2010; 257:782-792.
12. Minematsu K, Li L, Fisher M, Sotak CH, Davis MA, Fiandaca MS. Diffusion-weighted magnetic resonance imaging: rapid and quantitative detection of focal brain ischemia. Neurology 1992; 42:235-240.
13. Ebinger M, Galinovic I, Rozanski M, Brunecker P, Endres M, Fiebach JB. Fluid-attenuated inversion recovery evolution within 12 hours from stroke onset: a reliable tissue clock? Stroke 2009; 41:250-255.
14. Aoki J, Kimura K, Iguchi Y etal. Intravenous thrombolysis based on diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch in acute stroke patients with unknown onset time. Cerebrovasc Dis 2011; 31:435-441.
15. Aoki J, Kimura K, Shibazaki K, Sakamoto Y. Negative fluid-attenuated inversion recovery- based intravenous thrombolysis using recombinant tissue plasminogen activator in acute stroke patients with unknown onset time. Cerebrovasc Dis Extra 2013; 3:35-45.
16. Barreto AD, Martin-Schild S, Hallevi H etal. Thrombolytic therapy for patients who wake-up with stroke. Stroke 2009; 40:827-832.
17. Cho AH, Sohn S-I, Han M-K etal. Safety and efficacy of MRI-based thrombolysis in unclear-onset stroke. Cerebrovasc Dis 2008; 25:572-579.
18. Breuer L, Schellinger PD, Huttner HB etal. Feasibility and safety of magnetic resonance imaging-based thrombolysis in patients with stroke on awakening: initial single-centre experience. Int J Stroke 2010; 5:68-73.
19. Ebinger M, Scheitz JF, Kufner A, Endres M, Fiebach JB, Nolte CH. MRI-based intravenous thrombolysis in stroke patients with unknown time of symptom onset. Eur J Neurol 2012; 19:348-350.
20. Thomalla G, Fiebach JB, Østergaard L etal. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP). Int J Stroke 2014; 9:829-836.
21. Ostrem JL, Saver JL, Alger JR etal. Acute basilar artery occlusion: diffusion-perfusion MRI characterization of tissue salvage in patients receiving intra-arterial stroke therapies. Stroke 2004; 35:e30-34.
22. Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3:692-694.
23. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-1587.
24. Saqqur M, Uchino K, Demchuk AM etal. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007; 38:948-954.
25. Wahlgren N, Ahmed N, Dávalos A etal. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. The Lancet 2007; 369:275-282.
26. Yamaguchi T, Mori E, Minematsu K etal. Alteplase at 0.6mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke 2006; 37:1810-1815.
27. Toyoda K, Koga M, Naganuma M etal. Routine use of intravenous low-dose recombinant tissue plasminogen activator in Japanese patients: general outcomes and prognostic factors from the SAMURAI register. Stroke 2009; 40:3591-3595.
28. Kang DW, Sohn SI, Hong KS etal. Reperfusion therapy in unclear-onset stroke based on MRI evaluation (RESTORE): a prospective multicenter study. Stroke 2012; 43:3278-3283.
29. Chao AC, Hsu HY, Chung CP etal. Outcomes of thrombolytic therapy for acute ischemic stroke in Chinese patients: the Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) study. Stroke 2010; 41:885-890.